These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15744089)

  • 21. Five recombinant fragments of human serum albumin-tools for the characterization of the warfarin binding site.
    Dockal M; Chang M; Carter DC; Rüker F
    Protein Sci; 2000 Aug; 9(8):1455-65. PubMed ID: 10975567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin.
    Panjehshahin MR; Bowmer CJ; Yates MS
    Biochem Pharmacol; 1991 Apr; 41(8):1227-33. PubMed ID: 1706921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Fatty Acids and Uremic Toxins on the Binding of Nateglinide, an Insulin Secretagogue, to Site II on Human Serum Albumin.
    Nishi K; Yano A; Tsukigawa K; Chuang VT; Otagiri M; Yamasaki K
    Biol Pharm Bull; 2022; 45(6):803-805. PubMed ID: 35650107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton nuclear magnetic resonance study on the multimode interactions of human serum albumin with drug molecules.
    Oida T
    J Biochem; 1986 Jul; 100(1):99-113. PubMed ID: 3759941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of thyroxine-albumin binding using high-performance affinity chromatography. I. Interactions at the warfarin and indole sites of albumin.
    Loun B; Hage DS
    J Chromatogr; 1992 Sep; 579(2):225-35. PubMed ID: 1429970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species differences of serum albumins: I. Drug binding sites.
    Kosa T; Maruyama T; Otagiri M
    Pharm Res; 1997 Nov; 14(11):1607-12. PubMed ID: 9434282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of N-B transition of human serum albumin on the specific drug-binding sites.
    Wanwimolruk S; Birkett DJ
    Biochim Biophys Acta; 1982 Dec; 709(2):247-55. PubMed ID: 6185151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of parenteral nutrition fluids on the binding of therapeutic drugs to human serum in vitro.
    Bailey DN; Briggs JR
    Ther Drug Monit; 2004 Feb; 26(1):31-4. PubMed ID: 14749546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of glycosylation on the drug binding of human serum albumin.
    Koizumi K; Ikeda C; Ito M; Suzuki J; Kinoshita T; Yasukawa K; Hanai T
    Biomed Chromatogr; 1998; 12(4):203-10. PubMed ID: 9667024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro stereoselective degradation of carprofen glucuronide by human serum albumin. Characterization of sites and reactive amino acids.
    Georges H; Presle N; Buronfosse T; Fournel-Gigleux S; Netter P; Magdalou J; Lapicque F
    Chirality; 2000 Feb; 12(2):53-62. PubMed ID: 10637410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species-dependent stereoselective drug binding to albumin: a circular dichroism study.
    Pistolozzi M; Bertucci C
    Chirality; 2008 Mar; 20(3-4):552-8. PubMed ID: 18172833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro plasma protein binding and aqueous aggregation behavior of astaxanthin dilysinate tetrahydrochloride.
    Zsila F; Fitos I; Bikádi Z; Simonyi M; Jackson HL; Lockwood SF
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5357-66. PubMed ID: 15454227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of site-specific binding and co-binding of ligands to human serum albumin using 19F NMR.
    Jenkins BG; Lauffer RB
    Mol Pharmacol; 1990 Jan; 37(1):111-8. PubMed ID: 2300044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies of verapamil binding to human serum albumin by high-performance affinity chromatography.
    Mallik R; Yoo MJ; Chen S; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(1):69-75. PubMed ID: 18980867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A spectroscopic study of the interaction of isoflavones with human serum albumin.
    Mahesha HG; Singh SA; Srinivasan N; Rao AG
    FEBS J; 2006 Feb; 273(3):451-67. PubMed ID: 16420470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of site-specific binding to plasma albumin in drug availability to brain.
    Mandula H; Parepally JM; Feng R; Smith QR
    J Pharmacol Exp Ther; 2006 May; 317(2):667-75. PubMed ID: 16410405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correspondence of fatty acid and drug binding sites on human serum albumin: a two-dimensional nuclear magnetic resonance study.
    Krenzel ES; Chen Z; Hamilton JA
    Biochemistry; 2013 Mar; 52(9):1559-67. PubMed ID: 23360066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steric and allosteric effects of fatty acids on the binding of warfarin to human serum albumin revealed by molecular dynamics and free energy calculations.
    Fujiwara S; Amisaki T
    Chem Pharm Bull (Tokyo); 2011; 59(7):860-7. PubMed ID: 21720037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ibuprofen and warfarin on the allosteric properties of haem-human serum albumin. A spectroscopic study.
    Baroni S; Mattu M; Vannini A; Cipollone R; Aime S; Ascenzi P; Fasano M
    Eur J Biochem; 2001 Dec; 268(23):6214-20. PubMed ID: 11733017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.